These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9748527)

  • 1. Enhanced sensitivity to topoisomerase inhibitors in synchronous CHO cells pre-treated with 5-azacytidine.
    López-Baena M; Mateos S; Piñero J; Trinidad Ortiz ; Cortés F
    Mutat Res; 1998 Oct; 421(1):109-16. PubMed ID: 9748527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effect of inhibitors of topoisomerase I and II on chromosome damage and cell killing in cultured Chinese hamster ovary cells.
    Cortés F; Piñero J
    Cancer Chemother Pharmacol; 1994; 34(5):411-5. PubMed ID: 8070008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A human small cell lung carcinoma cell line, resistant to 4'-(9-acridinylamino)-methanesulfon-m-anisidide and cross-resistant to camptothecin with a high level of topoisomerase I.
    Prost S; Riou G
    Biochem Pharmacol; 1994 Aug; 48(5):975-84. PubMed ID: 8093110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of replication fork progression for the induction of chromosome damage and SCE by inhibitors of DNA topoisomerases.
    Cortés F; Piñero J; Ortiz T
    Mutat Res; 1993 Oct; 303(2):71-6. PubMed ID: 7692280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction effects of 5-azacytidine with topoisomerase II inhibitors on CHO cells, as detected by cytogenetic analysis.
    Takahashi-Hyodo SA; Sakamoto-Hojo ET; Takahashi CS
    Mutat Res; 1999 Dec; 431(1):13-23. PubMed ID: 10656482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons.
    D'Arpa P; Beardmore C; Liu LF
    Cancer Res; 1990 Nov; 50(21):6919-24. PubMed ID: 1698546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetical characterization of Chinese hamster ovary X-ray-sensitive mutant cells, xrs 5 and xrs 6. IV. Study of chromosomal aberrations and sister-chromatid exchanges by restriction endonucleases and inhibitors of DNA topoisomerase II.
    Darroudi F; Natarajan AT
    Mutat Res; 1989 Jun; 212(2):137-48. PubMed ID: 2543922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA topoisomerase I as a site of action for 10-hydroxycamptothecin in human promyelocytic leukemia cells.
    Ling YH; Andersson BS; Nelson JA
    Cancer Biochem Biophys; 1990 Jan; 11(1):23-30. PubMed ID: 2159843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The concentration-dependent diversity of effects of DNA topoisomerase I and II inhibitors on the cell cycle of HL-60 cells.
    Del Bino G; Skierski JS; Darzynkiewicz Z
    Exp Cell Res; 1991 Aug; 195(2):485-91. PubMed ID: 1649059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sister chromatid exchanges, chromosomal aberrations, and cytotoxicity produced by antitumor topoisomerase II inhibitors in sensitive (DC3F) and resistant (DC3F/9-OHE) Chinese hamster cells.
    Pommier Y; Kerrigan D; Covey JM; Kao-Shan CS; Whang-Peng J
    Cancer Res; 1988 Feb; 48(3):512-6. PubMed ID: 2825977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotoxicity of inhibitors of DNA topoisomerases I (camptothecin) and II (m-AMSA) in vivo and in vitro.
    Backer LC; Allen JW; Harrington-Brock K; Campbell JA; DeMarini DM; Doerr CL; Howard DR; Kligerman AD; Moore MM
    Mutagenesis; 1990 Nov; 5(6):541-7. PubMed ID: 2175833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels of DNA topoisomerases in cultured CHO cells treated with the antitumour drug 5-azacytidine.
    Piñero J; López-Baena M; Ortiz T; Mateos S; Cortés F
    Cytobios; 1999; 97(385):103-15. PubMed ID: 10418121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA demethylation protects from cleavable complex stabilization and DNA strand breakage induced by the topoisomerase type I inhibitor camptothecin.
    Orta ML; Mateos S; Cortés F
    Mutagenesis; 2009 May; 24(3):237-44. PubMed ID: 19201781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of 4'-(9-acridinylamino)methanesulfon-m-anisidide-induced, topoisomerase II-mediated DNA cleavage by gossypol.
    Adlakha RC; Ashorn CL; Chan D; Zwelling LA
    Cancer Res; 1989 Apr; 49(8):2052-8. PubMed ID: 2539251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of purified mitochondrial DNA topoisomerase I from bovine liver to camptothecin and m-AMSA.
    Lin JH; Castora FJ
    Arch Biochem Biophys; 1995 Dec; 324(2):293-9. PubMed ID: 8554321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in a human leukemia cell line.
    Kaufmann SH
    Cancer Res; 1991 Feb; 51(4):1129-36. PubMed ID: 1705167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of cytotoxicity and DNA damage induced by the topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cells.
    Jensen LH; Dejligbjerg M; Hansen LT; Grauslund M; Jensen PB; Sehested M
    BMC Pharmacol; 2004 Dec; 4():31. PubMed ID: 15575955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic effects of inhibition of topoisomerase I or II activities in the CHO mutant EM9 and its parental line AA8.
    Cortés F; Piñero J; Palitti F
    Mutat Res; 1993 Aug; 288(2):281-9. PubMed ID: 7688089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of ER-37328, a novel carbazole topoisomerase II inhibitor.
    Nakamura K; Sugumi H; Yamaguchi A; Uenaka T; Kotake Y; Okada T; Kamata J; Niijima J; Nagasu T; Koyanagi N; Yoshino H; Kitoh K; Yoshimatsu K
    Mol Cancer Ther; 2002 Jan; 1(3):169-75. PubMed ID: 12467211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DNA demethylating 5-azaC induces endoreduplication in cultured Chinese hamster cells.
    Mateos S; Domínguez I; Pastor N; Cantero G; Cortés F
    Mutat Res; 2005 Oct; 578(1-2):33-42. PubMed ID: 16202795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.